# Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117

> **NCT02505191** · PHASE1 · COMPLETED · sponsor: **Max Zeller Soehne AG** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** St. John's wort prolonged-release tablet 500 mg
- **DRUG:** St. John's wort film coated tablets 250 mg

## Key facts

- **NCT ID:** NCT02505191
- **Lead sponsor:** Max Zeller Soehne AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02505191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02505191, "Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02505191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*